abrocitinib;
itching;
JAK inhibitor;
prurigo nodularis;
D O I:
10.1002/ccr3.8606
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK-STAT signaling may significantly improve prurigo nodularis. Based on the results, we would like to draw a conclusion that abrocitinib as an inhibitor of Jak is a promising choice for the treatment of prurigo nodularis.
机构:
Univ Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USAUniv Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USA
Beck, Kristen M.
Yang, Eric J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USAUniv Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USA
Yang, Eric J.
Sekhon, Sahil
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USAUniv Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USA
Sekhon, Sahil
Bhutani, Tina
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USAUniv Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USA
Bhutani, Tina
Liao, Wilson
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USAUniv Calif San Francisco, Dept Dermatol, 515 Spruce St, San Francisco, CA 94118 USA